Twitxy Saved

Embolx

Verified account This account is verified. Learn more

@EmbolxInc

Embolx develops innovative, high-quality balloon occlusion microcatheters for the treatment of cancerous tumors, benign prostatic hyperplasia & uterine fibroids
Sunnyvale, CA embolx.com Joined March 2017
310 Following 282 Followers 178 Posts

Latest posts 5

Pinned post

Embolx Verified account @EmbolxInc
📣 Big news for interventional oncology access!

CMS has established a new HCPCS Level II code, G0577, covering pressure-generating catheter procedures in the physician office / OBL setting - effective July 1, 2026.

This is the result of a multi-year effort we led in close collaboration with CMS, and it's a meaningful step toward giving more patients access to advanced embolization care in a lower-cost site of service.

"Our center has utilized the Sniper microcatheter for years because it consistently improves clinical outcomes for our patients," said Dr. Aaron Fischman, Mount Sinai. "This new G-code is a significant milestone."

Read the full announcement 👇
bit.ly/4pnniAf
#InterventionalRadiology #OBL #Embolization #IRad
www.prnewswire.com Embolx Secures New CMS HCPCS Level II G-Code for Pressure-Generating Catheter Procedures Performed... /PRNewswire/ -- Embolx, Inc., a leader in advanced microcatheter technology for targeted embolization procedures, today announced that the Centers for Medicare...
Embolx Verified account @EmbolxInc
We’re excited to be part of SIR 2026 and invite you to join us at the Innovation Hub for an engaging session on advancing embolization techniques.

“Clinical Advantages of Balloon Embolization”
🗣️ Dr. Jeremy Kim - Charlotte Radiology
🗓 Monday, April 13
🕛 12:10 PM
📍 Innovation Hub – Exhibit Floor

Dr. @JeremyKimMD will review the evolution, mechanism, and clinical performance of balloon-assisted embolization across TACE, Y90, and PAE. Attendees will gain a clear understanding of the key technical principles and clinical benefits supporting balloon embolization as an advanced approach in IR procedures.

Stop by to learn, connect, and explore how innovation is shaping the future of interventional radiology!
#SIR2026 #InterventionalRadiology #MedTech #Embolization #InnovationHub
Embolx Verified account @EmbolxInc
What happened to my complete response? 🤔

We know the sobering reality: even after a successful conventional embolization procedure, up to 50% of patients see disease progression within just 6 months, and 76% within one year [Ilagan et al]. This constant threat of recurrence is the critical unmet need that must be solved.

The Solution: High-Pressure Embolization.

Balloon occlusion can be used to achieve high-pressure delivery, pushing the endpoint beyond stasis.

It's time to redefine what a complete response looks like for advanced-stage HCC patients.

Click below to read the data👇
bit.ly/4p8sDdv

#HCC #InterventionalOncology #MedicalDevices #PatientCare

MK-0662
Embolx Verified account @EmbolxInc
🚫 Stasis ≠ No Blood Flow in TACE

Stasis slows flow but doesn’t guarantee tumor fill. The result? Viable tumor cells, retreatments, and less durable responses.

With pressure embolization using Sniper, IRs can push past stasis – delivering embolic material more completely, achieving deeper tumor fill and significantly improving durability of Complete Response.

Interested in learning more about pressure-directed embolization with Sniper? Let’s connect.

#InterventionalRadiology #MedicalInnovation
#Embolization #PressureDirectedTherapy #MedTech

Young et al., Ilagan et al.
MK-0661
Embolx Verified account @EmbolxInc
Are you tired of seeing high recurrence rates in TAE and TACE procedures? Angiographic complete response is often fleeting, with alarming rates of disease progression.

Learn how Embolx provides a more lasting and effective treatment👉bit.ly/4mGHxWQ
#Embolization #IRad
www.linkedin.com #tae #tace #innovation #irad #medtech #embolization | Embolx, Inc. 🔍 The problem with current TAE and TACE embolization techniques Are you tired of seeing high recurrence rates in transarterial embolization (TAE) and transarterial chemoembolization (TACE) procedu...